Healthcare provider profile · identity verified

Paul Breiding, MD

Internal Medicine · PROVIDENCE, RI · NPI 1073567343

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	654	166
Lisinopril	Lisinopril	415	106
Amlodipine Besylate	Amlodipine Besylate	314	90
Levothyroxine Sodium	Levothyroxine Sodium	253	65
Metformin Hcl	Metformin Hcl	203	53
Omeprazole	Omeprazole	198	59
Losartan Potassium	Losartan Potassium	193	54
Metoprolol Succinate	Metoprolol Succinate	189	50
Tamsulosin Hcl	Tamsulosin Hcl	170	46
Simvastatin	Simvastatin	160	41
Allopurinol	Allopurinol	158	41
Rosuvastatin Calcium	Rosuvastatin Calcium	154	47
Gabapentin	Gabapentin	153	40
Escitalopram Oxalate	Escitalopram Oxalate	143	37
Eliquis	Apixaban	135	30
Pantoprazole Sodium	Pantoprazole Sodium	135	39
Alprazolam	Alprazolam	123	35
Hydrochlorothiazide	Hydrochlorothiazide	122	33
Meloxicam	Meloxicam	117	34
Famotidine	Famotidine	115	37
Zolpidem Tartrate	Zolpidem Tartrate	114	23
Lorazepam	Lorazepam	112	27
Sertraline Hcl	Sertraline Hcl	112	27
Azithromycin	Azithromycin	109	97
Albuterol Sulfate Hfa	Albuterol Sulfate	108	39
Prednisone	Prednisone	99	59
Pravastatin Sodium	Pravastatin Sodium	97	27
Metoprolol Tartrate	Metoprolol Tartrate	93	24
Fluticasone Propionate	Fluticasone Propionate	90	33
Citalopram Hbr	Citalopram Hydrobromide	89	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	87	20
Oxycodone Hcl	Oxycodone Hcl	81	26
Furosemide	Furosemide	77	25
Fluoxetine Hcl	Fluoxetine Hcl	70	17
Atenolol	Atenolol	67	21
Chlorthalidone	Chlorthalidone	65	20
Clonazepam	Clonazepam	64	16
Ciprofloxacin Hcl	Ciprofloxacin Hcl	59	44
Donepezil Hcl	Donepezil Hcl	57	suppressed
Trazodone Hcl	Trazodone Hcl	57	22
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	56	49
Warfarin Sodium	Warfarin Sodium	53	12
Synthroid	Levothyroxine Sodium	52	suppressed
Duloxetine Hcl	Duloxetine Hcl	51	14
Mirtazapine	Mirtazapine	51	12
Metformin Hcl Er	Metformin Hcl	50	19
Doxycycline Hyclate	Doxycycline Hyclate	48	33
Doxazosin Mesylate	Doxazosin Mesylate	41	12
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	39	suppressed
Fenofibrate	Fenofibrate	38	suppressed
Cephalexin	Cephalexin	36	29
Levofloxacin	Levofloxacin	36	29
Colchicine	Colchicine	34	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	34	28
Valacyclovir	Valacyclovir Hcl	33	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	32	suppressed
Tizanidine Hcl	Tizanidine Hcl	32	16
Finasteride	Finasteride	30	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	30	suppressed
Valsartan	Valsartan	30	suppressed
Amoxicillin	Amoxicillin	29	24
Lamotrigine	Lamotrigine	28	suppressed
Tramadol Hcl	Tramadol Hcl	28	17
Wixela Inhub	Fluticasone Propion/Salmeterol	27	suppressed
Clopidogrel	Clopidogrel Bisulfate	26	suppressed
Bupropion Hcl Sr	Bupropion Hcl	25	suppressed
Diazepam	Diazepam	25	suppressed
Spironolactone	Spironolactone	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	12
Glimepiride	Glimepiride	24	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	23	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	23	23
Ibuprofen	Ibuprofen	22	11
Incruse Ellipta	Umeclidinium Bromide	22	suppressed
Montelukast Sodium	Montelukast Sodium	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Lansoprazole	Lansoprazole	21	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Lidocaine	Lidocaine	20	suppressed
Nitroglycerin	Nitroglycerin	20	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Ozempic	Semaglutide	20	suppressed
Xarelto	Rivaroxaban	20	suppressed
Jardiance	Empagliflozin	19	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	19	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Nystatin	Nystatin	18	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Cefuroxime	Cefuroxime Axetil	16	16
Entresto	Sacubitril/Valsartan	16	suppressed
Erythromycin	Erythromycin Base	16	16
Ezetimibe	Ezetimibe	16	suppressed
Naproxen	Naproxen	16	suppressed
Prazosin Hcl	Prazosin Hcl	16	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Ramipril	Ramipril	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	suppressed
Topiramate	Topiramate	14	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	13	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	13	suppressed
Dilt-Xr	Diltiazem Hcl	13	suppressed
Hydrocortisone Valerate	Hydrocortisone Valerate	13	suppressed
Estradiol	Estradiol	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Felodipine Er	Felodipine	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Terbinafine Hcl	Terbinafine Hcl	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Metronidazole	Metronidazole	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error